IDIBAPS Doctoral programme Yielding Novel Advancements in Medicine and Innovative Solutions
▶Summary
Addressing the increased need for innovative solutions in medicine requires nurturing and training of highly skilled translational researchers, understanding patients´ needs and driving research to address them, mastering innovative technologies, navigating ethics and regulations, and facilitating interdisciplinary and intersectoral collaborations. The IDIBAPS research institute is uniquely located in the Campus Clínic in Barcelona, joining efforts with the University of Barcelona and the Hospital Clínic, carrying out cutting-edge translational research to improve prevention, diagnosis, and treatment of most common diseases in our society. The novel DYNAMIS programme will train 10 excellent junior translational researchers to carry out original PhD research projects in Translational Medicine. Recruited through two open, merit-based international competitive calls, the Doctoral Candidates (DCs) will benefit from high-quality co-supervision by a more fundamental and a clinical researcher and will engage in a training and career development programme in a vibrant research and innovation environment, opening them up a wide variety of career paths in academia and the private sector. DYNAMIS will offer the highest quality standards of scientific integrity and social responsibility, following the principles of the European charter and code for researchers, and the fundamentals of innovative training. DYNAMIS has partnered with 33 Associated Partners, including hospitals, patient groups, SMEs, health clusters and tech companies to offer training, supervision and secondment opportunities, enhancing the employability of the DCs through inter-sectorial exposure. By the end of the doctoral programme, the DYNAMIS fellows will have gained scientific and transferrable skills, including knowledge and experience on how to incorporate the patients´ perspective in research, to advance their career at the forefront of medicine and science.